The Italian Association of Medical Oncology reported that as a result of the Covid-19 pandemic, in the first 5 months…
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
Interview with Fiorella Guadagni, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Pisana
Can you briefly describe the Institute? The Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Pisana –…
Launch of the EU REVERT project – Targeted Therapy for Cororectal Cancer Patients
“Revert (Targeted Therapy for Cororectal Cancer Patients)” is a European Project funded by the European Union’s Horizon 2020 research and…
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.